Literature DB >> 10568787

Antisense properties of peptide nucleic acids.

U Soomets1, M Hällbrink, U Langel.   

Abstract

PNA is a nucleic acid analog with an achiral polyamide backbone consisting of N-(2-aminoethyl)glycine units (figure 1). The purine or pyrimidine bases are linked to the each unit via a methylene carbonyl linker (1-3) to target the complementary nucleic acid (4). PNA binds to complementary RNA or DNA in a parallel or antiparallel orientation following the Watson-Crick base-pairing rules (5-7). The uncharged nature of the PNA oligomers enhances the stability of the hybrid PNA/DNA(RNA) duplexes as compared to the natural homoduplexes. The non-natural character of the PNA makes PNA oligomers highly resistant to protease and nuclease attacks (8). These properties of PNA oligomers suggest that they could potentially serve as efficient antisense or antigene reagents. Indeed, peptide nucleic acids have been applied to block protein expression on the transcriptional (9) and translational level (10,11), and microinjected PNA oligomers demonstrate a strong antisense effect in intact cells (12). However, contrary to the "normal" nucleic acid analogs, PNA oligomers are not efficiently delivered into the cytoplasm of the cell, and until recently this has hindered the application of PNA oligomers as antisense reagents. In this work we summarize some recent achievements on PNA antisense application, especially these concerned with whole cell or tissue delivery of the PNA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568787     DOI: 10.2741/soomets

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  7 in total

1.  Insights into peptide nucleic acid (PNA) structural features: the crystal structure of a D-lysine-based chiral PNA-DNA duplex.

Authors:  Valeria Menchise; Giuseppina De Simone; Tullia Tedeschi; Roberto Corradini; Stefano Sforza; Rosangela Marchelli; Domenica Capasso; Michele Saviano; Carlo Pedone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

Review 2.  microRNA therapies in cancer.

Authors:  Sacha I Rothschild
Journal:  Mol Cell Ther       Date:  2014-03-04

3.  Fluorescence detection of KRAS2 mRNA hybridization in lung cancer cells with PNA-peptides containing an internal thiazole orange.

Authors:  Mahesh V Sonar; Matthew E Wampole; Yuan-Yuan Jin; Chang-Po Chen; Mathew L Thakur; Eric Wickstrom
Journal:  Bioconjug Chem       Date:  2014-09-02       Impact factor: 4.774

Review 4.  The Regulatory Role of MicroRNAs in EMT and Cancer.

Authors:  Apostolos Zaravinos
Journal:  J Oncol       Date:  2015-03-25       Impact factor: 4.375

Review 5.  Triazole-Modified Nucleic Acids for the Application in Bioorganic and Medicinal Chemistry.

Authors:  Dagmara Baraniak; Jerzy Boryski
Journal:  Biomedicines       Date:  2021-05-31

Review 6.  From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).

Authors:  Roberta Piva; Demetrios A Spandidos; Roberto Gambari
Journal:  Int J Oncol       Date:  2013-08-12       Impact factor: 5.650

7.  Translational Inhibition of CTX-M Extended Spectrum β-Lactamase in Clinical Strains of Escherichia coli by Synthetic Antisense Oligonucleotides Partially Restores Sensitivity to Cefotaxime.

Authors:  John B Readman; George Dickson; Nick G Coldham
Journal:  Front Microbiol       Date:  2016-03-24       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.